The Globe and Mail

Go to the Globe and Mail homepage

Jump to main navigationJump to main content

AdChoices
 

Baxter International Inc

NYSE: BAX
Last

(U.S.) $36.61

Today's change+0.73 +2.03%
Updated February 12 4:01 PM EST. Delayed by at least 15 minutes.
 

Baxter International Inc

NYSE: BAX
Last

(U.S.) $36.61

Today's change+0.73 +2.03%
Updated February 12 4:01 PM EST. Delayed by at least 15 minutes.

Baxter International Inc crosses above 125-day moving average

Baxter International Inc closed up sharply Friday, rallying (U.S.)$0.73 or 2.03% to (U.S.)$36.61 and crossing above its 125-day moving average. Over the last five days, shares have lost 2.35% and are down 4.04% for the last year to date. This security has underperformed the S&P 500 by 37.05% during the last year.

Key company metrics

  • Open(U.S.) $36.11
  • Previous close(U.S.) $35.88
  • High(U.S.) $36.63
  • Low(U.S.) $35.79
  • Bid / Ask-- / --
  • YTD % change-4.04%
  • Volume3,560,892
  • Average volume (10-day)6,416,940
  • Average volume (1-month)5,926,110
  • Average volume (3-month)5,098,518
  • 52-week range(U.S.) $32.18 to (U.S.) $72.84
  • Beta0.64
  • Trailing P/E50.27×
  • P/E 1 year forward24.32×
  • Forward PEG2.21×
  • Indicated annual dividend(U.S.) $0.46
  • Dividend yield1.26%
  • Trailing EPS(U.S.) $0.73
Updated February 12 4:01 PM EST. Delayed by at least 15 minutes.

Profit

Net Profit (TTM)
+4.01%

Based on its net profit margin of 4.01%, Baxter International Inc is among the more effective companies in its industry at turning revenues into bottom line profit.
Company Books

S&P TSX2.43%Sector:HealthcareIndustry:Medical Equipment, Supplies & Distribution
  • Income Statement
  • Balance Sheet
  • Cash Flow
Quarter | Annual
Q4/2015Q3/2015Q2/2015Q1/2015
Fiscal Quarter Endvalues in (U.S.) $ millions unless otherwise notedDec 31, 201512/31/2015Sep 30, 201509/30/2015Jun 30, 201506/30/2015Mar 31, 201503/31/2015
Revenue2,6032,4873,8933,764
Total other revenue--------
Total revenue2,6032,4873,8933,764
Gross profit1,0721,0491,9261,795
Total cost of revenue1,5311,4381,9671,969
Total operating expense2,4252,5253,4583,278
Selling / general / administrative733670951887
Research & development161140292298
Depreciation / amortization--------
Interest expense (income), net operating--------
Unusual expense (income)--277248124
Other operating expenses, total--------
Operating income178-38435486
Interest income (expense), net non-operating---38-40-35
Gain (loss) on sale of assets--------
Other--------
Income before tax205-33468530
Income after tax1902336420
Income tax, total15-35132110
Net income2051332430
Total adjustments to net income--------
Net income before extra. items1902336420
Minority interest--------
Equity in affiliates--------
U.S. GAAP adjustment--------
Inc. avail. to common excl. extra. items1902336420
Inc. avail. to common incl. extra. items2051332430
Diluted net income2051332430
Dilution adjustment--------
Diluted weighted average shares550549549548
Diluted EPS excluding extraordinary itemsvalue per share0.350.000.610.77
Dividends per sharevalue per share0.120.120.520.52
Diluted normalized EPSvalue per share0.350.341.000.91